Production of pharmaceutical proteins by transgenic animals

Abstract Proteins started being used as pharmaceuticals in the 1920s with insulin extracted from pig pancreas. In the early 1980s, human insulin was prepared in recombinant bacteria and it is now used by all patients suffering from diabetes. Several other proteins and particularly human growth hormone are also prepared from bacteria. This success was limited by the fact that bacteria cannot synthesize complex proteins such as monoclonal antibodies or coagulation blood factors which must be matured by post-translational modifications to be active or stable in vivo. These modifications include mainly folding, cleavage, subunit association, γ-carboxylation and glycosylation. They can be fully achieved only in mammalian cells which can be cultured in fermentors at an industrial scale or used in living animals. Several transgenic animal species can produce recombinant proteins but presently two systems started being implemented. The first is milk from farm transgenic mammals which has been studied for 20 years and which allowed a protein, human antithrombin III, to receive the agreement from EMEA (European Agency for the Evaluation of Medicinal Products) to be put on the market in 2006. The second system is chicken egg white which recently became more attractive after essential improvement of the methods used to generate transgenic birds. Two monoclonal antibodies and human interferon-β1a could be recovered from chicken egg white. A broad variety of recombinant proteins were produced experimentally by these systems and a few others. This includes monoclonal antibodies, vaccines, blood factors, hormones, growth factors, cytokines, enzymes, milk proteins, collagen, fibrinogen and others. Although these tools have not yet been optimized and are still being improved, a new era in the production of recombinant pharmaceutical proteins was initiated in 1987 and became a reality in 2006. In the present review, the efficiency of the different animal systems to produce pharmaceutical proteins are described and compared to others including plants and micro-organisms.

[1]  D. Kaslow,et al.  A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Baranyi,et al.  High Level Expression of Tissue-Nonspecific Alkaline Phosphatase in the Milk of Transgenic Rabbits , 2006, Transgenic Research.

[3]  L. Houdebine,et al.  Use of Transgenic Animals to Improve Human Health and Animal Production , 2005, Reproduction in domestic animals = Zuchthygiene.

[4]  Emilio Fernández,et al.  Transgenic microalgae as green cell-factories. , 2004, Trends in biotechnology.

[5]  L. Houdebine,et al.  The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. , 1996, Reproduction, nutrition, development.

[6]  H. Luboń,et al.  Transgenic animal bioreactors in biotechnology and production of blood proteins. , 1998, Biotechnology annual review.

[7]  Paul Chamberlain,et al.  Biopharmaceutical production in plants: problems, solutions and opportunities. , 2005, Trends in biotechnology.

[8]  L. Houdebine,et al.  Position‐independent and tissue‐specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice , 2002, Molecular reproduction and development.

[9]  R. Yanagimachi,et al.  Simultaneous removal of sperm plasma membrane and acrosome before intracytoplasmic sperm injection improves oocyte activation/embryonic development , 2006, Proceedings of the National Academy of Sciences.

[10]  James E. Bailey,et al.  Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.

[11]  L. Houdebine.  Transgenic animal models in biomedical research. , 2007, Methods in molecular biology.

[12]  Rainer Fischer,et al.  Plant cell cultures for the production of recombinant proteins , 2004, Nature Biotechnology.

[13]  P. Manavalan,et al.  Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. , 1998, Blood.

[14]  P. Couble,et al.  Biosynthesis and cocoon-export of a recombinant globular protein in transgenic silkworms , 2005, Transgenic Research.

[15]  Jean Cohen,et al.  Production of Two Vaccinating Recombinant Rotavirus Proteins in the Milk of Transgenic Rabbits , 2005, Transgenic Research.

[16]  Rongfeng Li,et al.  Production of a transgenic piglet by a sperm injection technique in which no chemical or physical treatments were used for oocytes or sperm , 2006, Molecular reproduction and development.

[17]  L. Houdebine.  The methods to generate transgenic animals and to control transgene expression. , 2002, Journal of biotechnology.

[18]  Houdebine Lm.  Use of Transgenic Animals to Improve Human Health and Animal Production , 2005 .

[19]  A. Sherman,et al.  Oviduct-specific expression of two therapeutic proteins in transgenic hens , 2007, Proceedings of the National Academy of Sciences.

[20]  L. Houdebine,et al.  Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery. , 2007, Vaccine.

[21]  L. Houdebine.  Antibody manufacture in transgenic animals and comparisons with other systems , 2002, Current Opinion in Biotechnology.

[22]  R. K. Peterson,et al.  Risk analysis for plant-made vaccines , 2005, Transgenic Research.

[23]  L. Montoliu,et al.  The Potential Benefits of Insulators on Heterologous Constructs in Transgenic Animals , 2003, Transgenic Research.

[24]  A. Rehemtulla,et al.  Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Houdebine,et al.  Preparation of recombinant proteins in milk to improve human and animal health. , 2006, Reproduction, nutrition, development.

[26]  A. Jevnikar,et al.  Transgenic rice for allergy immunotherapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Arcalis,et al.  Plants as bioreactors: a comparative study suggests that Medicago truncatula is a promising production system. , 2005, Journal of biotechnology.

[28]  J. Lofgren,et al.  Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins , 1999, Nature Biotechnology.

[29]  M. Delany,et al.  Germline transmission of genetically modified primordial germ cells , 2006, Nature.

[30]  Teresa Mitchell,et al.  Production of complex human glycoproteins in yeast. , 2003, Science.

[31]  J. Kamerling,et al.  N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. , 2003, Glycobiology.

[32]  P. A. Zamora,et al.  High expression level of recombinant human erythropoietin in the milk of non-transgenic goats. , 2006, Journal of biotechnology.

[33]  J. Marshall,et al.  Production of Cystic Fibrosis Transmembrane Conductance Regulator in the Milk of Transgenic Mice , 1992, Bio/Technology.

[34]  M. Sirard,et al.  Making recombinant proteins in animals--different systems, different applications. , 2003, Trends in biotechnology.

[35]  A. Pfeifer.  Lentiviral transgenesis--a versatile tool for basic research and gene therapy. , 2006, Current gene therapy.

[36]  R. Jefferis.  A sugar switch for anti-inflammatory antibodies , 2006, Nature Biotechnology.

[37]  F. Grosveld,et al.  Stable expression of human growth hormone over 50 generations in transgenic insect larvae , 2007, Transgenic Research.

[38]  J. Castilla,et al.  Production of cattle lacking prion protein , 2007, Nature Biotechnology.

[39]  L. Houdebine.  Transgenic animal bioreactors , 2004, Transgenic Research.

[40]  Shrikant Deshpande,et al.  Production of human monoclonal antibody in eggs of chimeric chickens , 2005, Nature Biotechnology.

[41]  P. Mozdziak,et al.  The incredible, edible, and therapeutic egg , 2007, Proceedings of the National Academy of Sciences.

[42]  Carola Engler,et al.  Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.